+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Zogenix Inc (ZGNX) - Financial and Strategic SWOT Analysis Review

  • ID: 4278387
  • SWOT Analysis
  • 48 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Amorsa Therapeutics Inc
  • Biocodex
  • GW Pharmaceuticals Plc
  • Insys Therapeutics Inc
  • Ovid Therapeutics Inc
  • Stoke Therapeutics Inc
  • MORE
Zogenix Inc (ZGNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

Key Information Included
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Zogenix Inc (Zogenix) is a pharmaceutical company with focus on central nervous system (CNS) disorders. It develops and commercializes therapies for rare CNS disorders. The company’s lead product candidate ZX008 (low dose fenfluramine) is intended for the treatment of Dravet syndrome and Lennox-Gastaut syndrome (LGS). ZX008 is in Phase III clinical trials and has orphan drug designation in the US and EU and secured Fast Track designation and breakthrough therapy designation from the US FDA. The company operates in the UK through its subsidiary Zogenix International, Ltd. Zogenix is headquartered in Emeryville, California, the US.

Zogenix Inc Key Recent Developments

Aug 06, 2019: Zogenix provides corporate update and reports second quarter 2019 financial results
May 08, 2019: Zogenix provides corporate update and reports first quarter 2019 financial results
Feb 28, 2019: Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2018 Financial Results
Aug 06, 2018: Zogenix provides corporate update and reports second quarter financial results
Jul 02, 2018: Zogenix Appoints Ashish Sagrolikar As New Global Chief Commercial Officer

Key Benefits

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Amorsa Therapeutics Inc
  • Biocodex
  • GW Pharmaceuticals Plc
  • Insys Therapeutics Inc
  • Ovid Therapeutics Inc
  • Stoke Therapeutics Inc
  • MORE
Section 1 - About the Company
  • Zogenix Inc - Key Facts
  • Zogenix Inc - Key Employees
  • Zogenix Inc - Key Employee Biographies
  • Zogenix Inc - Major Products and Services
  • Zogenix Inc - History
  • Zogenix Inc - Company Statement
  • Zogenix Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 – Company Analysis
  • Company Overview
  • Zogenix Inc - Business Description
  • R&D Overview
  • Zogenix Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Zogenix Inc - Strengths
  • Zogenix Inc - Weaknesses
  • Zogenix Inc - Opportunities
  • Zogenix Inc - Threats
  • Zogenix Inc - Key Competitors
Section 3 – Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
  • Zogenix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Zogenix Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • Zogenix Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
  • Aug 06, 2019: Zogenix provides corporate update and reports second quarter 2019 financial results
  • May 08, 2019: Zogenix provides corporate update and reports first quarter 2019 financial results
  • Feb 28, 2019: Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2018 Financial Results
  • Aug 06, 2018: Zogenix provides corporate update and reports second quarter financial results
  • Jul 02, 2018: Zogenix Appoints Ashish Sagrolikar As New Global Chief Commercial Officer
  • May 09, 2018: Zogenix Provides Corporate Update and Reports First Quarter Financial Results
  • Mar 06, 2018: Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results
Section 6 – Appendix
  • Methodology
  • Ratio Definitions
  • About the Author
  • Contact Us
  • Disclaimer
List of Tables
  • Zogenix Inc, Key Facts
  • Zogenix Inc, Key Employees
  • Zogenix Inc, Key Employee Biographies
  • Zogenix Inc, Major Products and Services
  • Zogenix Inc, History
  • Zogenix Inc, Other Locations
  • Zogenix Inc, Subsidiaries
  • Zogenix Inc, Key Competitors
  • Zogenix Inc, Ratios based on current share price
  • Zogenix Inc, Annual Ratios
  • Zogenix Inc, Interim Ratios
  • Zogenix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Zogenix Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • Zogenix Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Zogenix Inc, Performance Chart (2014 - 2018)
  • Zogenix Inc, Ratio Charts
  • Zogenix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Zogenix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Xenon Pharmaceuticals Inc
  • Stoke Therapeutics Inc
  • Ovid Therapeutics Inc
  • Insys Therapeutics Inc
  • GW Pharmaceuticals Plc
  • Biocodex
  • Amorsa Therapeutics Inc
  • Acadia Pharmaceuticals Inc
Note: Product cover images may vary from those shown
Adroll
adroll